• Sosei Heptares to Receive Milestone Payment from Formosa Pharmaceuticals americanpharmaceuticalreview
    July 22, 2019
    osei Group announces Formosa Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for APP13007 to commence a first-in-human (FIH) clinical trial in the United States.
PharmaSources Customer Service